Disease model characterization and development of assays to evaluate and measure pain in a porcine model for sickle cell disease (SCD)
Ended Awarded Last action
- Contract number
- 75N95019F00088
- Awardee
-
Lovelace Biomedical Research Institute UEI MBT9RXJJ7428
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $4,969,241
Award facts
- Opportunity
-
- CRO Support for NCATS Animal Model Development and In Vivo Pharmacology Studies and Related Services Pre-Solicitation · N01TR192005 · Posted Mar 13, 2018
- Contract value 100% obligated
- $4,969,241.33 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albuquerque, NM 87108, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | -$165,600 | |
| Supplemental Agreement for work within scope | $675,487 | |
| Supplemental Agreement for work within scope | $227,165 | |
| Supplemental Agreement for work within scope | $255,356 | |
| Supplemental Agreement for work within scope | $594,812 | |
| Supplemental Agreement for work within scope | $414,878 | |
| Other Administrative Action | $57,400 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $1,952,502 | |
| Funding Only Action | $123,638 | |
| Original award | $833,604 |
Show all 11
About this award
This is a $4,969,241.33 cost-plus-fixed-fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for the characterization of disease models and development of assays to evaluate and measure pain in a porcine (pig) model for sickle cell disease (SCD). The contract has an ultimate completion date of September 30, 2024 and does not utilize any set-aside designations. Lovelace Biomedical Research Institute has previously held federal contract and grant awards from agencies such as the National Institutes of Health (NIH), Department of Defense (DoD), and Department of Health and Human Services (HHS) for various preclinical research projects.
Quick answers
Who was awarded contract 75N95019F00088?
75N95019F00088 was awarded to Lovelace Biomedical Research Institute by National Institute on Drug Abuse (National Institutes of Health) on July 1, 2019.
How much is contract 75N95019F00088 worth?
The government has obligated $4,969,241 on 75N95019F00088.
Which agency awarded contract 75N95019F00088?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95019F00088, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95019F00088 an order under another contract?
Yes. 75N95019F00088 is a delivery order under 75N95019D00012, an indefinite delivery contract.
Was contract 75N95019F00088 competed?
The extent of competition for 75N95019F00088 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award